Current status and temporal trend of disease burden of thyroid cancer in China from 1990 to 2019

Objective Thyroid cancer has been an increasingly high‐profile public health issue. Comprehensive assessment for its disease burden seems particularly important for understanding health priorities and hinting high‐risk populations. Methods We estimated the age‐sex‐specific thyroid cancer burden and...

Full description

Saved in:
Bibliographic Details
Published inAsia-Pacific journal of clinical oncology Vol. 19; no. 1; pp. 196 - 205
Main Authors Zhang, Meng‐Ni, Liang, Xiao‐Yu, Li, Mao‐Ting, Zhi, Xin‐Yue, Yan, Qiu‐Yu, Zhu, Hong, Xie, Juan
Format Journal Article
LanguageEnglish
Published Australia Wiley Subscription Services, Inc 01.02.2023
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Objective Thyroid cancer has been an increasingly high‐profile public health issue. Comprehensive assessment for its disease burden seems particularly important for understanding health priorities and hinting high‐risk populations. Methods We estimated the age‐sex‐specific thyroid cancer burden and its temporal trend in China from 1990 to 2019 by following the general methods from the global burden of disease (GBDs) 2019 Study. And Joinpoint regression model, the Cox‐Stuart trend test, and Cochran‐Armitage test were applied for the analysis of temporal and age trend. The Mantel‐Haenszel statistical method was used to compare the gender difference. Results From 1990 to 2019, the age‐standardized incidence rate of thyroid cancer in China has almost doubled to 2.05 per 100,000. Although the mortality rate and DALY rate kept leveling off, they presented a downtrend among females, while an upward trend in males. While the average annual percentage changes of those metrics all became deline since 2010 than the previous years. With age advancing, the rates of incidence, mortality, and DALYs for both sexes all presented linear fashion increases, which was particularly typical among males. Conclusion Given the serious trend and gender‐age heterogeneity of Chinese thyroid cancer burden, male gender and advanced age may be related to poor prognosis of thyroid cancer, and strengthening primary prevention and exploring the underlying risk factors should be among the top priorities. Although the incidence of thyroid cancer in Chinese population was lower than the global average, given the huge population base, the burden of thyroid cancer disease in China cannot be ignored, especially the fatal burden among males in China.
AbstractList Abstract Objective Thyroid cancer has been an increasingly high‐profile public health issue. Comprehensive assessment for its disease burden seems particularly important for understanding health priorities and hinting high‐risk populations. Methods We estimated the age‐sex‐specific thyroid cancer burden and its temporal trend in China from 1990 to 2019 by following the general methods from the global burden of disease (GBDs) 2019 Study. And Joinpoint regression model, the Cox‐Stuart trend test, and Cochran‐Armitage test were applied for the analysis of temporal and age trend. The Mantel‐Haenszel statistical method was used to compare the gender difference. Results From 1990 to 2019, the age‐standardized incidence rate of thyroid cancer in China has almost doubled to 2.05 per 100,000. Although the mortality rate and DALY rate kept leveling off, they presented a downtrend among females, while an upward trend in males. While the average annual percentage changes of those metrics all became deline since 2010 than the previous years. With age advancing, the rates of incidence, mortality, and DALYs for both sexes all presented linear fashion increases, which was particularly typical among males. Conclusion Given the serious trend and gender‐age heterogeneity of Chinese thyroid cancer burden, male gender and advanced age may be related to poor prognosis of thyroid cancer, and strengthening primary prevention and exploring the underlying risk factors should be among the top priorities.
OBJECTIVEThyroid cancer has been an increasingly high-profile public health issue. Comprehensive assessment for its disease burden seems particularly important for understanding health priorities and hinting high-risk populations. METHODSWe estimated the age-sex-specific thyroid cancer burden and its temporal trend in China from 1990 to 2019 by following the general methods from the global burden of disease (GBDs) 2019 Study. And Joinpoint regression model, the Cox-Stuart trend test, and Cochran-Armitage test were applied for the analysis of temporal and age trend. The Mantel-Haenszel statistical method was used to compare the gender difference. RESULTSFrom 1990 to 2019, the age-standardized incidence rate of thyroid cancer in China has almost doubled to 2.05 per 100,000. Although the mortality rate and DALY rate kept leveling off, they presented a downtrend among females, while an upward trend in males. While the average annual percentage changes of those metrics all became deline since 2010 than the previous years. With age advancing, the rates of incidence, mortality, and DALYs for both sexes all presented linear fashion increases, which was particularly typical among males. CONCLUSIONGiven the serious trend and gender-age heterogeneity of Chinese thyroid cancer burden, male gender and advanced age may be related to poor prognosis of thyroid cancer, and strengthening primary prevention and exploring the underlying risk factors should be among the top priorities.
Thyroid cancer has been an increasingly high-profile public health issue. Comprehensive assessment for its disease burden seems particularly important for understanding health priorities and hinting high-risk populations. We estimated the age-sex-specific thyroid cancer burden and its temporal trend in China from 1990 to 2019 by following the general methods from the global burden of disease (GBDs) 2019 Study. And Joinpoint regression model, the Cox-Stuart trend test, and Cochran-Armitage test were applied for the analysis of temporal and age trend. The Mantel-Haenszel statistical method was used to compare the gender difference. From 1990 to 2019, the age-standardized incidence rate of thyroid cancer in China has almost doubled to 2.05 per 100,000. Although the mortality rate and DALY rate kept leveling off, they presented a downtrend among females, while an upward trend in males. While the average annual percentage changes of those metrics all became deline since 2010 than the previous years. With age advancing, the rates of incidence, mortality, and DALYs for both sexes all presented linear fashion increases, which was particularly typical among males. Given the serious trend and gender-age heterogeneity of Chinese thyroid cancer burden, male gender and advanced age may be related to poor prognosis of thyroid cancer, and strengthening primary prevention and exploring the underlying risk factors should be among the top priorities.
Objective Thyroid cancer has been an increasingly high‐profile public health issue. Comprehensive assessment for its disease burden seems particularly important for understanding health priorities and hinting high‐risk populations. Methods We estimated the age‐sex‐specific thyroid cancer burden and its temporal trend in China from 1990 to 2019 by following the general methods from the global burden of disease (GBDs) 2019 Study. And Joinpoint regression model, the Cox‐Stuart trend test, and Cochran‐Armitage test were applied for the analysis of temporal and age trend. The Mantel‐Haenszel statistical method was used to compare the gender difference. Results From 1990 to 2019, the age‐standardized incidence rate of thyroid cancer in China has almost doubled to 2.05 per 100,000. Although the mortality rate and DALY rate kept leveling off, they presented a downtrend among females, while an upward trend in males. While the average annual percentage changes of those metrics all became deline since 2010 than the previous years. With age advancing, the rates of incidence, mortality, and DALYs for both sexes all presented linear fashion increases, which was particularly typical among males. Conclusion Given the serious trend and gender‐age heterogeneity of Chinese thyroid cancer burden, male gender and advanced age may be related to poor prognosis of thyroid cancer, and strengthening primary prevention and exploring the underlying risk factors should be among the top priorities. Although the incidence of thyroid cancer in Chinese population was lower than the global average, given the huge population base, the burden of thyroid cancer disease in China cannot be ignored, especially the fatal burden among males in China.
Author Zhang, Meng‐Ni
Xie, Juan
Li, Mao‐Ting
Zhu, Hong
Liang, Xiao‐Yu
Zhi, Xin‐Yue
Yan, Qiu‐Yu
Author_xml – sequence: 1
  givenname: Meng‐Ni
  surname: Zhang
  fullname: Zhang, Meng‐Ni
  organization: Nutrition and Public Health
– sequence: 2
  givenname: Xiao‐Yu
  surname: Liang
  fullname: Liang, Xiao‐Yu
  organization: Tianjin Medical University General Hospital
– sequence: 3
  givenname: Mao‐Ting
  surname: Li
  fullname: Li, Mao‐Ting
  organization: Nutrition and Public Health
– sequence: 4
  givenname: Xin‐Yue
  surname: Zhi
  fullname: Zhi, Xin‐Yue
  organization: Nutrition and Public Health
– sequence: 5
  givenname: Qiu‐Yu
  surname: Yan
  fullname: Yan, Qiu‐Yu
  organization: Nutrition and Public Health
– sequence: 6
  givenname: Hong
  surname: Zhu
  fullname: Zhu, Hong
  organization: Nutrition and Public Health
– sequence: 7
  givenname: Juan
  orcidid: 0000-0002-7841-6749
  surname: Xie
  fullname: Xie, Juan
  email: xiejuan@tmu.edu.cn
  organization: Nutrition and Public Health
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35692103$$D View this record in MEDLINE/PubMed
BookMark eNp9kMFq3DAQhkXZ0N1se-kDFEEvJbCJZFmSdVxMmyYE9pK7MpbGxIstbSWbsm8fbzbNoYfOZYaZj4_hvySLEAMS8oWzaz7XDexdvOaiYuwDWXFdio2WSizeZymX5DLnPWPCFIZ_JEshlSk4EyvyVE8pYRhpHmGcMoXg6YjDISbo6ThfPI0t9V1GyEibKXkMp834fEyx89RBcJhoF2j93AWgbYoD5cYwOkZaMG4-kYsW-oyf3_qaPP788Vj_2jzsbu_q7cPGCanZpnCofdlKLHQJ2pUKwEjfyLZRjfIaGlZVSnooVQPYaGfAGyNEq0teIQqxJt_P2kOKvyfMox267LDvIWCcsi2UlqZSiqsZ_fYPuo9TCvNzttBaaCZEeRJenSmXYs4JW3tI3QDpaDmzp9jtKXb7GvsMf31TTs2A_h39m_MM8DPwp-vx-B-V3d7Xu7P0BQ3ijSM
CitedBy_id crossref_primary_10_22141_2224_0721_20_3_2024_1387
crossref_primary_10_1016_j_heliyon_2023_e22490
crossref_primary_10_1186_s13044_024_00191_x
crossref_primary_10_2147_IJGM_S461708
crossref_primary_10_1002_jum_16429
Cites_doi 10.1002/ijc.33298
10.2217/fon.10.127
10.1038/s41574-019-0263-x
10.1038/s41598-020-79176-3
10.1111/j.1365-2184.2007.00471.x
10.1016/S0140-6736(12)60278-5
10.1177/1010539512436874
10.1001/jamaoncol.2015.1426
10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z
10.1001/jamaoncol.2015.0735
10.1089/thy.2017.0102
10.1016/S2213-8587(21)00083-8
10.3322/caac.21262
10.1093/eurpub/ckq120
10.1016/j.jncc.2022.02.002
10.1001/jamaoncol.2021.6987
10.1056/NEJMp1604412
10.3322/caac.21439
10.1016/S1470-2045(19)30339-0
10.1002/cncr.33392
10.1056/NEJMp1409841
10.1016/S0140-6736(20)30977-6
10.1002/sim.3733
10.1089/thy.2015.0613
10.1177/0962280211406424
10.1007/s10552-018-1023-2
10.1158/1055-9965.EPI-08-0976
10.3389/fendo.2021.655608
10.1001/jamaoncol.2019.2996
10.1093/aje/kwp354
10.1016/j.ypmed.2019.105849
10.3322/caac.21660
10.1089/thy.2016.0100
10.1111/j.1365-2265.2006.02605.x
10.12659/MSM.892035
10.1016/S0140-6736(19)30427-1
10.1146/annurev-med-061512-105739
10.1002/cncr.22754
10.1016/S1470-2045(20)30073-5
10.1016/S0140-6736(20)30925-9
10.1111/cen.13254
10.1002/cncr.29747
10.1097/00130404-200503000-00006
ContentType Journal Article
Copyright 2022 John Wiley & Sons Australia, Ltd.
2023 John Wiley & Sons Australia, Ltd.
Copyright_xml – notice: 2022 John Wiley & Sons Australia, Ltd.
– notice: 2023 John Wiley & Sons Australia, Ltd.
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7TO
H94
7X8
DOI 10.1111/ajco.13800
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Oncogenes and Growth Factors Abstracts
AIDS and Cancer Research Abstracts
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Oncogenes and Growth Factors Abstracts
AIDS and Cancer Research Abstracts
MEDLINE - Academic
DatabaseTitleList CrossRef
MEDLINE - Academic
MEDLINE
Oncogenes and Growth Factors Abstracts

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Public Health
EISSN 1743-7563
EndPage 205
ExternalDocumentID 10_1111_ajco_13800
35692103
AJCO13800
Genre article
Journal Article
GeographicLocations China
GeographicLocations_xml – name: China
GrantInformation_xml – fundername: National Natural Science Foundation of China
  funderid: 81602922
– fundername: National Natural Science Foundation of China
  grantid: 81602922
GroupedDBID ---
.3N
.GA
05W
0R~
10A
1OC
23N
31~
33P
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AASGY
AAXRX
AAZKR
ABCQN
ABCUV
ABDBF
ABEML
ABJNI
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFPM
AFGKR
AFPWT
AFZJQ
AHBTC
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
EBD
EBS
EJD
EMOBN
ESX
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZ~
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
Q.N
Q11
QB0
R.K
ROL
RX1
SUPJJ
SV3
TEORI
TUS
UB1
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQJ
WRC
WVDHM
WXSBR
XG1
ZZTAW
~IA
~WT
ACXME
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7TO
H94
7X8
ID FETCH-LOGICAL-c3570-2ce7d4f5e274a7c46aa95db5fb6b6d7ab08865da46baeb7c9ad9933f7418ee33
IEDL.DBID DR2
ISSN 1743-7555
IngestDate Fri Aug 16 04:05:21 EDT 2024
Fri Sep 13 04:17:31 EDT 2024
Fri Aug 23 01:04:27 EDT 2024
Thu May 23 23:32:32 EDT 2024
Sat Aug 24 01:07:59 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords cancer burden
thyroid cancer
epidemiological distribution
age-sex distribution
disability-adjusted life years
Language English
License 2022 John Wiley & Sons Australia, Ltd.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3570-2ce7d4f5e274a7c46aa95db5fb6b6d7ab08865da46baeb7c9ad9933f7418ee33
Notes These authors contributed equally to this study.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-7841-6749
PMID 35692103
PQID 2773703343
PQPubID 2045194
PageCount 10
ParticipantIDs proquest_miscellaneous_2675986616
proquest_journals_2773703343
crossref_primary_10_1111_ajco_13800
pubmed_primary_35692103
wiley_primary_10_1111_ajco_13800_AJCO13800
PublicationCentury 2000
PublicationDate February 2023
2023-Feb
2023-02-00
20230201
PublicationDateYYYYMMDD 2023-02-01
PublicationDate_xml – month: 02
  year: 2023
  text: February 2023
PublicationDecade 2020
PublicationPlace Australia
PublicationPlace_xml – name: Australia
– name: Chichester
PublicationTitle Asia-Pacific journal of clinical oncology
PublicationTitleAlternate Asia Pac J Clin Oncol
PublicationYear 2023
Publisher Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc
References 2021; 9
2015; 1
2018; 29
2017; 86
2019; 5
2021; 148
2017; 27
2021; 127
2020; 16
2016; 122
2014; 371
2020; 10
2019; 129S
2021; 71
2014; 23
1959; 22
2014; 65
2009; 28
2018; 68
2001; 81
2000; 19
2015; 27
2021; 12
2019; 20
2020; 396
2006; 65
2007; 110
2022; 8
2015; 65
2015; 21
2016; 375
2011; 21
2007; 40
2022; 2
2020; 21
2010; 171
2019; 394
2012; 379
2016; 26
2003; 63
2005; 11
2010; 6
2009; 18
2007; 26
e_1_2_12_4_1
e_1_2_12_6_1
e_1_2_12_19_1
e_1_2_12_2_1
e_1_2_12_17_1
e_1_2_12_38_1
Xu X (e_1_2_12_39_1) 2003; 63
e_1_2_12_20_1
e_1_2_12_41_1
e_1_2_12_22_1
e_1_2_12_43_1
e_1_2_12_24_1
e_1_2_12_45_1
e_1_2_12_26_1
e_1_2_12_49_1
e_1_2_12_33_1
e_1_2_12_35_1
e_1_2_12_37_1
e_1_2_12_14_1
e_1_2_12_12_1
e_1_2_12_8_1
Mantel N (e_1_2_12_28_1) 1959; 22
e_1_2_12_10_1
e_1_2_12_50_1
e_1_2_12_3_1
e_1_2_12_5_1
e_1_2_12_18_1
Su XH (e_1_2_12_47_1) 2007; 26
e_1_2_12_16_1
e_1_2_12_42_1
e_1_2_12_21_1
e_1_2_12_44_1
e_1_2_12_23_1
e_1_2_12_46_1
e_1_2_12_25_1
e_1_2_12_48_1
Guan H (e_1_2_12_31_1) 2001; 81
e_1_2_12_40_1
e_1_2_12_27_1
e_1_2_12_29_1
e_1_2_12_30_1
e_1_2_12_32_1
e_1_2_12_34_1
e_1_2_12_36_1
e_1_2_12_15_1
e_1_2_12_13_1
e_1_2_12_11_1
e_1_2_12_7_1
e_1_2_12_51_1
e_1_2_12_9_1
References_xml – volume: 27
  start-page: NP223
  issue: 2
  year: 2015
  end-page: NP229
  article-title: Increasing incidence of thyroid cancer in Shanghai, China, 1983–2007
  publication-title: Asia Pac J Public Health
– volume: 19
  start-page: 335
  issue: 3
  year: 2000
  end-page: 351
  article-title: Permutation tests for Joinpoint regression with applications to cancer rates
  publication-title: Stat Med
– volume: 23
  start-page: 218
  issue: 3
  year: 2014
  end-page: 243
  article-title: On the power of the Cochran‐Armitage test for trend in the presence of misclassification
  publication-title: Stat Methods Med Res
– volume: 22
  start-page: 719
  issue: 4
  year: 1959
  end-page: 748
  article-title: Statistical aspects of the analysis of data from retrospective studies of disease
  publication-title: J Natl Cancer Inst
– volume: 2
  start-page: 1
  issue: 1
  year: 2022
  end-page: 9
  article-title: Cancer incidence and mortality in China, 2016
  publication-title: J Natl Cancer Center
– volume: 1
  start-page: 425
  issue: 4
  year: 2015
  end-page: 427
  article-title: Novel methods for measuring global cancer burden: implications for global cancer control
  publication-title: JAMA Oncol
– volume: 1
  start-page: 505
  issue: 4
  year: 2015
  end-page: 527
  article-title: The global burden of cancer 2013
  publication-title: JAMA oncology
– volume: 394
  start-page: 1145
  issue: 10204
  year: 2019
  end-page: 1158
  article-title: Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: a systematic analysis for the global burden of disease study 2017
  publication-title: Lancet (London, England)
– volume: 21
  start-page: 573
  issue: 5
  year: 2011
  end-page: 577
  article-title: The validity of the mortality to incidence ratio as a proxy for site‐specific cancer survival
  publication-title: Eur J Public Health
– volume: 26
  start-page: 1541
  issue: 11
  year: 2016
  end-page: 1552
  article-title: Systematic review of trends in the incidence rates of thyroid cancer
  publication-title: Thyroid
– volume: 27
  start-page: 751
  issue: 6
  year: 2017
  end-page: 756
  article-title: Updated American joint committee on cancer/tumor‐node‐metastasis staging system for differentiated and anaplastic thyroid cancer (eighth edition): what changed and why?
  publication-title: Thyroid
– volume: 5
  start-page: 1749
  issue: 12
  year: 2019
  end-page: 1768
  article-title: Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability‐adjusted life‐years for 29 cancer groups, 1990 to 2017: a systematic analysis for the global burden of disease study
  publication-title: JAMA oncology
– volume: 12
  year: 2021
  article-title: Extent of surgery and the prognosis of unilateral papillary thyroid microcarcinoma
  publication-title: Front Endocrinol (Lausanne)
– volume: 65
  start-page: 364
  issue: 3
  year: 2006
  end-page: 368
  article-title: The BRAF mutation is useful for prediction of clinical recurrence in low‐risk patients with conventional papillary thyroid carcinoma
  publication-title: Clin Endocrinol (Oxf)
– volume: 171
  start-page: 242
  issue: 2
  year: 2010
  end-page: 252
  article-title: Nonradiation risk factors for thyroid cancer in the US radiologic technologists study
  publication-title: Am J Epidemiol
– volume: 28
  start-page: 3670
  issue: 29
  year: 2009
  end-page: 3682
  article-title: Estimating average annual per cent change in trend analysis
  publication-title: Stat Med
– volume: 86
  start-page: 438
  issue: 3
  year: 2017
  end-page: 443
  article-title: Optimal cut‐off age in the TNM staging system of differentiated thyroid cancer: is 55 years better than 45 years?
  publication-title: Clin Endocrinol (Oxf)
– volume: 148
  start-page: 1106
  issue: 5
  year: 2021
  end-page: 1114
  article-title: Screening and the epidemic of thyroid cancer in China: an analysis of national representative inpatient and commercial insurance databases
  publication-title: Int J Cancer
– volume: 81
  start-page: 457
  issue: 8
  year: 2001
  end-page: 458
  article-title: Comparative epidemiological study on thyroid cancer in areas with different iodine intakes
  publication-title: Zhonghua Yi Xue Za Zhi
– volume: 20
  start-page: 1211
  issue: 9
  year: 2019
  end-page: 1225
  article-title: The global burden of childhood and adolescent cancer in 2017: an analysis of the global burden of disease study 2017
  publication-title: The Lancet Oncology
– volume: 396
  start-page: 1160
  issue: 10258
  year: 2020
  end-page: 1203
  article-title: Global age‐sex‐specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic analysis for the global burden of disease study 2019
  publication-title: Lancet (London, England)
– volume: 129S
  year: 2019
  article-title: Mortality‐to‐incidence ratios by US congressional district: implications for epidemiologic, dissemination and implementation research, and public health policy
  publication-title: Prev Med
– volume: 9
  start-page: 330
  issue: 6
  year: 2021
  end-page: 332
  article-title: Mapping overdiagnosis of thyroid cancer in China
  publication-title: Lancet Diabetes Endocrinol
– volume: 18
  start-page: 1092
  issue: 4
  year: 2009
  end-page: 1100
  article-title: Gender is an age‐specific effect modifier for papillary cancers of the thyroid gland
  publication-title: Cancer Epidemiol Biomarkers Prev
– volume: 26
  start-page: 1125
  issue: 8
  year: 2016
  end-page: 1130
  article-title: Iodine status and prevalence of thyroid disorders after introduction of mandatory universal salt iodization for 16 years in china: a cross‐sectional study in 10 cities
  publication-title: Thyroid
– volume: 16
  start-page: 17
  issue: 1
  year: 2020
  end-page: 29
  article-title: Geographic influences in the global rise of thyroid cancer
  publication-title: Nat Rev Endocrinol
– volume: 11
  start-page: 113
  issue: 2
  year: 2005
  end-page: 121
  article-title: Induction of thyroid papillary carcinoma cell proliferation by estrogen is associated with an altered expression of Bcl‐xL
  publication-title: Cancer J
– volume: 71
  start-page: 209
  issue: 3
  year: 2021
  end-page: 249
  article-title: Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
  publication-title: CA Cancer J Clin
– volume: 68
  start-page: 55
  issue: 1
  year: 2018
  end-page: 63
  article-title: Differentiated and anaplastic thyroid carcinoma: major changes in the American joint committee on cancer eighth edition cancer staging manual
  publication-title: CA Cancer J Clin
– volume: 21
  start-page: 283
  year: 2015
  end-page: 291
  article-title: Obesity and risk of thyroid cancer: evidence from a meta‐analysis of 21 observational studies
  publication-title: Med Sci Monit
– volume: 63
  start-page: 4561
  issue: 15
  year: 2003
  end-page: 4567
  article-title: High prevalence of BRAF gene mutation in papillary thyroid carcinomas and thyroid tumor cell lines
  publication-title: Cancer Res
– volume: 65
  start-page: 125
  year: 2014
  end-page: 137
  article-title: Thyroid cancer
  publication-title: Annu Rev Med
– volume: 6
  start-page: 1771
  issue: 11
  year: 2010
  end-page: 1779
  article-title: Thyroid cancer gender disparity
  publication-title: Future Oncol
– volume: 110
  start-page: 38
  issue: 1
  year: 2007
  end-page: 46
  article-title: Clinicopathologic significance of BRAF V600E mutation in papillary carcinomas of the thyroid: a meta‐analysis
  publication-title: Cancer
– volume: 40
  start-page: 921
  issue: 6
  year: 2007
  end-page: 935
  article-title: Oestrogen mediates the growth of human thyroid carcinoma cells via an oestrogen receptor‐ERK pathway
  publication-title: Cell Prolif
– volume: 26
  start-page: 67
  year: 2007
  end-page: 69
  publication-title: Chinese Journal of Endemiology.
– volume: 375
  start-page: 614
  issue: 7
  year: 2016
  end-page: 617
  article-title: Worldwide thyroid‐cancer epidemic? The increasing impact of overdiagnosis
  publication-title: N Engl J Med
– volume: 127
  start-page: 1448
  issue: 9
  year: 2021
  end-page: 1458
  article-title: Associations between artificial light at night and risk for thyroid cancer: a large US cohort study
  publication-title: Cancer
– volume: 10
  issue: 1
  year: 2020
  article-title: National burden of cancer in Italy, 1990–2017: a systematic analysis for the global burden of disease study 2017
  publication-title: Sci Rep
– volume: 371
  start-page: 1765
  issue: 19
  year: 2014
  end-page: 1767
  article-title: Korea's thyroid‐cancer “epidemic”–screening and overdiagnosis
  publication-title: N Engl J Med
– volume: 379
  start-page: 805
  issue: 9818
  year: 2012
  end-page: 814
  article-title: Trends in access to health services and financial protection in China between 2003 and 2011: a cross‐sectional study
  publication-title: Lancet (London, England)
– volume: 8
  start-page: 420
  issue: 3
  year: 2022
  end-page: 444
  article-title: Cancer incidence, mortality, years of life lost, years lived with disability, and disability‐adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis for the global burden of disease study 2019
  publication-title: JAMA Oncology
– volume: 396
  start-page: 1204
  issue: 10258
  year: 2020
  end-page: 1222
  article-title: Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of disease study 2019
  publication-title: Lancet (London, England)
– volume: 122
  start-page: 486
  issue: 3
  year: 2016
  end-page: 487
  article-title: Conceptual considerations and methodological recommendations for the use of the mortality‐to‐incidence ratio in time‐lagged, ecological‐level analysis for public health systems‐oriented cancer research
  publication-title: Cancer
– volume: 29
  start-page: 465
  issue: 4‐5
  year: 2018
  end-page: 473
  article-title: An update in international trends in incidence rates of thyroid cancer, 1973–2007
  publication-title: Cancer Causes Control
– volume: 21
  start-page: e342
  issue: 7
  year: 2020
  end-page: e349
  article-title: Cancer registration in China and its role in cancer prevention and control
  publication-title: The Lancet Oncology
– volume: 65
  start-page: 87
  issue: 2
  year: 2015
  end-page: 108
  article-title: Global cancer statistics, 2012
  publication-title: CA Cancer J Clin
– volume: 1
  start-page: 425
  issue: 4
  year: 2015
  end-page: 427
  article-title: Novel methods for measuring global cancer burden: implications for global cancer control
  publication-title: JAMA Oncology
– ident: e_1_2_12_45_1
  doi: 10.1002/ijc.33298
– ident: e_1_2_12_33_1
  doi: 10.2217/fon.10.127
– ident: e_1_2_12_2_1
  doi: 10.1038/s41574-019-0263-x
– ident: e_1_2_12_16_1
  doi: 10.1038/s41598-020-79176-3
– ident: e_1_2_12_42_1
  doi: 10.1111/j.1365-2184.2007.00471.x
– ident: e_1_2_12_46_1
  doi: 10.1016/S0140-6736(12)60278-5
– ident: e_1_2_12_30_1
  doi: 10.1177/1010539512436874
– ident: e_1_2_12_17_1
  doi: 10.1001/jamaoncol.2015.1426
– ident: e_1_2_12_24_1
  doi: 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z
– ident: e_1_2_12_8_1
  doi: 10.1001/jamaoncol.2015.0735
– ident: e_1_2_12_36_1
  doi: 10.1089/thy.2017.0102
– ident: e_1_2_12_43_1
  doi: 10.1016/S2213-8587(21)00083-8
– ident: e_1_2_12_4_1
  doi: 10.3322/caac.21262
– ident: e_1_2_12_20_1
  doi: 10.1093/eurpub/ckq120
– ident: e_1_2_12_5_1
  doi: 10.1016/j.jncc.2022.02.002
– ident: e_1_2_12_12_1
  doi: 10.1001/jamaoncol.2021.6987
– volume: 63
  start-page: 4561
  issue: 15
  year: 2003
  ident: e_1_2_12_39_1
  article-title: High prevalence of BRAF gene mutation in papillary thyroid carcinomas and thyroid tumor cell lines
  publication-title: Cancer Res
  contributor:
    fullname: Xu X
– ident: e_1_2_12_7_1
  doi: 10.1056/NEJMp1604412
– ident: e_1_2_12_37_1
  doi: 10.3322/caac.21439
– ident: e_1_2_12_15_1
  doi: 10.1016/S1470-2045(19)30339-0
– ident: e_1_2_12_50_1
  doi: 10.1002/cncr.33392
– ident: e_1_2_12_51_1
  doi: 10.1001/jamaoncol.2015.1426
– ident: e_1_2_12_6_1
  doi: 10.1056/NEJMp1409841
– ident: e_1_2_12_11_1
  doi: 10.1016/S0140-6736(20)30977-6
– ident: e_1_2_12_23_1
  doi: 10.1002/sim.3733
– ident: e_1_2_12_29_1
  doi: 10.1089/thy.2015.0613
– ident: e_1_2_12_27_1
  doi: 10.1177/0962280211406424
– volume: 22
  start-page: 719
  issue: 4
  year: 1959
  ident: e_1_2_12_28_1
  article-title: Statistical aspects of the analysis of data from retrospective studies of disease
  publication-title: J Natl Cancer Inst
  contributor:
    fullname: Mantel N
– ident: e_1_2_12_9_1
  doi: 10.1007/s10552-018-1023-2
– ident: e_1_2_12_34_1
  doi: 10.1158/1055-9965.EPI-08-0976
– ident: e_1_2_12_21_1
  doi: 10.1001/jamaoncol.2021.6987
– volume: 26
  start-page: 67
  year: 2007
  ident: e_1_2_12_47_1
  publication-title: Chinese Journal of Endemiology.
  contributor:
    fullname: Su XH
– ident: e_1_2_12_26_1
  doi: 10.3389/fendo.2021.655608
– ident: e_1_2_12_22_1
  doi: 10.1001/jamaoncol.2019.2996
– ident: e_1_2_12_49_1
  doi: 10.1093/aje/kwp354
– ident: e_1_2_12_18_1
  doi: 10.1016/j.ypmed.2019.105849
– ident: e_1_2_12_3_1
  doi: 10.3322/caac.21660
– ident: e_1_2_12_32_1
  doi: 10.1089/thy.2016.0100
– ident: e_1_2_12_38_1
  doi: 10.1111/j.1365-2265.2006.02605.x
– ident: e_1_2_12_48_1
  doi: 10.12659/MSM.892035
– ident: e_1_2_12_14_1
  doi: 10.1016/S0140-6736(19)30427-1
– ident: e_1_2_12_44_1
  doi: 10.1146/annurev-med-061512-105739
– ident: e_1_2_12_40_1
  doi: 10.1002/cncr.22754
– volume: 81
  start-page: 457
  issue: 8
  year: 2001
  ident: e_1_2_12_31_1
  article-title: Comparative epidemiological study on thyroid cancer in areas with different iodine intakes
  publication-title: Zhonghua Yi Xue Za Zhi
  contributor:
    fullname: Guan H
– ident: e_1_2_12_13_1
  doi: 10.1016/S1470-2045(20)30073-5
– ident: e_1_2_12_10_1
  doi: 10.1016/S0140-6736(20)30925-9
– ident: e_1_2_12_35_1
  doi: 10.1111/cen.13254
– ident: e_1_2_12_19_1
  doi: 10.1002/cncr.29747
– ident: e_1_2_12_41_1
  doi: 10.1097/00130404-200503000-00006
– ident: e_1_2_12_25_1
SSID ssj0039291
Score 2.332785
Snippet Objective Thyroid cancer has been an increasingly high‐profile public health issue. Comprehensive assessment for its disease burden seems particularly...
Thyroid cancer has been an increasingly high-profile public health issue. Comprehensive assessment for its disease burden seems particularly important for...
Abstract Objective Thyroid cancer has been an increasingly high‐profile public health issue. Comprehensive assessment for its disease burden seems particularly...
ObjectiveThyroid cancer has been an increasingly high‐profile public health issue. Comprehensive assessment for its disease burden seems particularly important...
OBJECTIVEThyroid cancer has been an increasingly high-profile public health issue. Comprehensive assessment for its disease burden seems particularly important...
SourceID proquest
crossref
pubmed
wiley
SourceType Aggregation Database
Index Database
Publisher
StartPage 196
SubjectTerms Age
age‐sex distribution
cancer burden
China - epidemiology
Cost of Illness
disability‐adjusted life years
epidemiological distribution
Female
Gender
Gender differences
Humans
Incidence
Male
Males
Mortality
Public health
Quality-Adjusted Life Years
Risk factors
Thyroid cancer
Thyroid Neoplasms - epidemiology
Title Current status and temporal trend of disease burden of thyroid cancer in China from 1990 to 2019
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fajco.13800
https://www.ncbi.nlm.nih.gov/pubmed/35692103
https://www.proquest.com/docview/2773703343/abstract/
https://search.proquest.com/docview/2675986616
Volume 19
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8QwEB4WD-LF92N1lYiehC7tpkm24GURRRZWQRS8SE3SFHzQym734q93po_VVRD0VtqEtJnMzDfNzBeAY59bLdHTeIKL1Ast114UucRLMZSQPZWmYZ8KhUdX8vIuHN6L-xacNrUwFT_E7IcbaUZpr0nBtZl8UXL9bPNuwBHwoAEmJj1CRDcz7ijy-0FVDck9JYSouUkpjeez67w3-gEx5xFr6XIuVuChedkq0-SlOy1M175_43H879eswnKNRdmgWjxr0HLZOiyO6t32DXisyZsYVR1NJ0xnCauprF5ZQcm0LE9ZvcXDTFkQQXdQ9uP8KWGWVtSYPWWsPKWbUSkLC9AxsSJnCAmiTbi9OL89u_TqExk8y4XyvZ51KglT4TCW1cqGUutIJEakRhqZKG3QZkmR6FAa7YyykU4Q__CUKHKc43wLFrI8cztAg2iEFwYBhgyF7Wk_cAh9fBlZ5wfWb8NRI5j4reLdiJt4heYqLueqDZ1GZnGte5O4pxRHO8ZD3obD2WPUGtoK0ZnLp9gG46Soj9hEtmG7kvVsGC5khIEw9j4pJfbL-PFgeHZdXu3-pfEeLNGp9VXydwcWivHU7SO2KcxBuYY_AJfY8Z4
link.rule.ids 315,786,790,1382,27957,27958,46329,46753
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fT9swED4NkMZe-A0rMDAaT0ipkjq2ySNCQx1QkFAn8RZsx5EKKJna9GV_PXeOW8YmIW1vUWLLiu_O95199xngOOZWS_Q0keCijFLLdZRlrohKDCVkT5VlekqFwoMb2f-RXt6L-5CbQ7UwLT_EfMONLMOv12TgtCH9m5XrR1t3E46IZwGW0N6Fj6ju5uxR5PmTth6SR0oIEdhJKZHnte9bf_QXyHyLWb3TuVhtb1adeK5CyjV56k4b07W__mBy_O__WYOVAEfZWas_6_DBVRvwcRAO3DfhIfA3MSo8mk6YrgoW2KyeWUP5tKwuWTjlYcbXRNAbFP-4HhXMklKN2ahi_qJuRtUsLEHfxJqaISrItmB48W143o_CpQyR5ULFUc86VaSlcBjOamVTqXUmCiNKI40slDa4bElR6FQa7YyymS4QAvGSWHKc43wbFqu6cp-BBtGIMAxiDJkK29Nx4hD9xDKzLk5s3IGvM8nkP1vqjXwWstBc5X6uOrA_E1oezG-S95TiuJTxlHfgaP4ZDYdOQ3Tl6im2QY3JThGeyA7stMKeD8OFzDAWxt4nXmTvjJ-fXZ7f-qfdf2l8CMv94eA6v_5-c7UHn-gS-zYXfB8Wm_HUfUGo05gDr9AvzF71wA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bS91AEB68gPhSa70dq3aLfRJySLI3A30R7UFttVIUfJG4VzhWEjnmvPjrO5vL8VIQ9C0ku2yyM7PzTXbmW4BvMTVKoKeJOOU-YoaqKMucjTyGEiKV3rPdUCh8cioOL9jxJb-cgu9dLUzDDzH54RYso16vg4HfWf_EyNWNKfsJRcAzDbNM0DTo9MGfCXlUcPxJUw5JI8k5b8lJQx7PY9_n7ug_jPkcstY-Z7AAV93bNqkmf_vjSvfNwwsix_d-zkf40IJRstdozyJMueITzJ202-1LcN2yN5FQdjS-J6qwpOWyuiVVyKYlpSftHg_RdUVEuIPCH5VDS0xQqREZFqQ-ppuEWhaSoGciVUkQE2TLcD74cb5_GLVHMkSGchlHqXHSMs8dBrNKGiaUyrjV3GuhhZVK46IluFVMaOW0NJmyCICoDxw5zlG6AjNFWbg1CIMoxBcaEYZg3KQqThxin1hkxsWJiXuw3Qkmv2uIN_IuYAlzlddz1YONTmZ5a3z3eSolxYWMMtqDr5PHaDZhL0QVrhxjGwyUsl0EJ6IHq42sJ8NQLjKMhLH3Ti2xV8bP9473f9dX629p_AXmzg4G-a-j05-fYT6cYN8kgm_ATDUau03EOZXeqtX5H_D_9G8
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Current+status+and+temporal+trend+of+disease+burden+of+thyroid+cancer+in+China+from+1990+to+2019&rft.jtitle=Asia-Pacific+journal+of+clinical+oncology&rft.au=Zhang%2C+Meng-Ni&rft.au=Liang%2C+Xiao-Yu&rft.au=Li%2C+Mao-Ting&rft.au=Zhi%2C+Xin-Yue&rft.date=2023-02-01&rft.eissn=1743-7563&rft.volume=19&rft.issue=1&rft.spage=196&rft_id=info:doi/10.1111%2Fajco.13800&rft_id=info%3Apmid%2F35692103&rft.externalDocID=35692103
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1743-7555&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1743-7555&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1743-7555&client=summon